Final COVID-19 Guidance Provides More Options for Trial Sponsors

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Final COVID-19 Guidance Provides More Options for Trial Sponsors

J.W. Schomisch

February 28, 2024 at 09:21 AM EST

A final guidance issued Feb. 21 provides sponsors with more options for assessing COVID-19-related symptoms in outpatient adult and adolescent subjects in clinical trials of drugs and biologicals for COVID-19 prevention or treatment than an earlier guidance. The guidance notes that “challenges persist” for sponsors conducting such trials. “These challenges include but are not... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Final COVID-19 Guidance Provides More Options for Trial Sponsors

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT